Unanswered questions following reports of secondary malignancies after CAR-T cell therapy

被引：128

作者：

Levine, Bruce L. ^{[1
,2
]}

Pasquini, Marcelo C. ^{[3
,4
]}

Connolly, John E. ^{[5
]}

Porter, David L. ^{[6
]}

Gustafson, Michael P. ^{[7
]}

Boelens, Jaap J. ^{[8
]}

Horwitz, Edwin M. ^{[9
]}

Grupp, Stephan A. ^{[10
,11
]}

Maus, Marcela V. ^{[12
,13
]}

Locke, Frederick L. ^{[14
]}

Ciceri, Fabio ^{[15
]}

Ruggeri, Annalisa ^{[16
]}

Snowden, John ^{[17
,18
]}

Heslop, Helen E. ^{[19
,20
,21
]}

Mackall, Crystal L. ^{[22
,23
,24
,25
]}

June, Carl H. ^{[1
,2
,26
]}

Sureda, Anna M. ^{[27
]}

Perales, Miguel-Angel ^{[28
,29
]}

机构：

[1] Univ Penn, Perelman Sch Med, Ctr Cellular Immunotherapies, Philadelphia, PA 19104 USA

[2] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA

[3] Med Coll Wisconsin, Dept Med, Div Hematol Oncol, Milwaukee, WI USA

[4] Med Coll Wisconsin, Ctr Int Blood & Marrow Transplant Res, Milwaukee, WI USA

[5] Parker Inst Canc Immunotherapy, San Francisco, CA USA

[6] Univ Penn, Perelman Sch Med, Abramson Canc Ctr, Cell Therapy & Transplant, Philadelphia, PA USA

[7] Mayo Clin Arizona, Dept Lab Med & Pathol, Phoenix, AZ USA

[8] Mem Sloan Kettering Canc Ctr, Transplantat & Cellular Therapy Serv, New York, NY USA

[9] Emory Univ, Winship Canc Inst, Aflac Canc & Blood Disorders Ctr, Sch Med,Dept Pediat, Atlanta, GA USA

[10] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA USA

[11] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA USA

[12] Mass Gen Canc Ctr, Cellular Immunotherapy Program, Cambridge, MA USA

[13] Harvard Med Sch, Cambridge, MA USA

[14] H Lee Moffitt Canc Ctr & Res Inst, Dept Blood & Marrow Transplant & Cellular Immunoth, Tampa, FL USA

[15] Univ Vita Salute San Raffaele, IRCCS San Raffaele Sci Inst Milano, Milan, Italy

[16] IRCCS San Raffaele Sci Inst, Hematol & BMT Unit, Milan, Italy

[17] Sheffield Teaching Hosp NHS Fdn Trust, Dept Haematol, Sheffield, England

[18] Univ Sheffield, Sch Med & Populat Hlth, Div Clin Med, Sheffield, England

[19] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX USA

[20] Texas Childrens Hosp, Houston, TX USA

[21] Houston Methodist Hosp, Houston, TX USA

[22] Stanford Univ, Stanford Canc Inst, Ctr Canc Cell Therapy, Palo Alto, CA USA

[23] Stanford Univ, Dept Pediat, Palo Alto, CA USA

[24] Stanford Univ, Dept Med, Palo Alto, CA USA

[25] Parker Inst Canc Immunotherapy, Palo Alto, CA USA

[26] Univ Penn, Parker Inst Canc Immunotherapy, Philadelphia, PA USA

[27] Univ Barcelona, Inst Catala Oncol LHospitalet, Clin Hematol Dept, IDIBELL, Barcelona, Spain

[28] Mem Sloan Kettering Canc Ctr, Adult Bone Marrow Transplantat Serv, Dept Med, New York, NY USA

[29] Weill Cornell Med Coll, Dept Med, New York, NY USA

来源：

NATURE MEDICINE | 2024年 / 30卷 / 02期

关键词：

D O I：

10.1038/s41591-023-02767-w

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Reports of T cell malignancies after CAR-T cell therapy should be investigated, but existing data from follow-up studies suggest a low risk compared with other cancer treatments.

引用

页码：338 / 341

页数：4

共 15 条

[1] T-cell lymphoma secondary to checkpoint inhibitor therapy [J].

Anand, Kartik ;

Ensor, Joe ;

Pingali, Sai Ravi ;

Hwu, Patrick ;

Duvic, Madeleine ;

Chiang, Stephen ;

Miranda, Roberto ;

Zu, Youli ;

Iyer, Swaminathan .

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (01)

[2] Increasing incidence of late second malignancies after conditioning with cyclophosphamide and total-body irradiation and autologous bone marrow transplantation for non-Hodgkin's lymphoma [J].

Brown, JR ;

Yeckes, H ;

Friedberg, JW ;

Neuberg, D ;

Kim, H ;

Nadler, LM ;

Freedman, AS .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (10) :2208-2214

[3] Clonal selection of hematopoietic stem cells after gene therapy for sickle cell disease [J].

Chapman, Michael Spencer ;

Cull, Alyssa H. ;

Ciuculescu, Marioara F. ;

Esrick, Erica B. ;

Mitchell, Emily ;

Jung, Hyunchul ;

O'Neill, Laura ;

Roberts, Kirsty ;

Fabre, Margarete A. ;

Williams, Nicholas ;

Nangalia, Jyoti ;

Quinton, Joanne ;

Fox, James M. ;

Pellin, Danilo ;

Makani, Julie ;

Armant, Myriam ;

Williams, David A. ;

Campbell, Peter J. ;

Kent, David G. .

NATURE MEDICINE, 2023, 29 (12) :3175-3183

[4] The bidirectional increased risk of B-cell lymphoma and T-cell lymphoma [J].

Chihara, Dai ;

Dores, Graca M. ;

Flowers, Christopher R. ;

Morton, Lindsay M. .

BLOOD, 2021, 138 (09) :785-789

[5] Replication competent retrovirus testing (RCR) in the National Gene Vector Biorepository: No evidence of RCR in 1,595 post-treatment peripheral blood samples obtained from 60 clinical trials [J].

Cornetta, Kenneth ;

Yao, Jing ;

House, Kimberley ;

Duffy, Lisa ;

Adusumilli, Prasad S. ;

Beyer, Rachel ;

Booth, Claire ;

Brenner, Malcolm ;

Curran, Kevin ;

Grilley, Bambi ;

Heslop, Helen ;

Hinrichs, Christian S. ;

Kaplan, Rosandra N. ;

Kiem, Hans-Peter ;

Kochenderfer, James ;

Kohn, Donald B. ;

Mailankody, Sham ;

Norberg, Scott M. ;

O'Cearbhaill, Roisin E. ;

Pappas, Jennifer ;

Park, Jae ;

Ramos, Carlos ;

Ribas, Antonio ;

Riviere, Isabelle ;

Rosenberg, Steven A. ;

Sauter, Craig ;

Shah, Nirali N. ;

Slovin, Susan F. ;

Thrasher, Adrian ;

Williams, David A. ;

Lin, Tsai-Yu .

MOLECULAR THERAPY, 2023, 31 (03) :801-809

[6]

Hamilton M. P., 2023, AM SOC HEMATOL

[7] CAR plus T-Cell Lymphoma Post Ciltacabtagene Autoleucel Therapy for Relapsed Refractory Multiple Myeloma [J].

Harrison, Simon J. ;

Nguyen, Tamia ;

Rahman, Marzia ;

Er, Jeremy ;

Li, Jessica ;

Li, Katherine ;

Lendvai, Nikoletta ;

Schecter, Jordan M. ;

Banerjee, Arnob ;

Roccia, Tito ;

Foulk, Brad ;

Gu, Junchen ;

Zhao, Hao ;

Smirnov, Denis ;

Slaughter, Ana ;

Lonardi, Carolina ;

Lee, Erin ;

Marquez, Loreta ;

Jadidi, Shirin ;

Costa Filho, Octavio ;

Patel, Nitin ;

Geng, Dong ;

Haynes, Nicole M. ;

Kelly, Hannah ;

Lade, Stephen ;

Grimmond, Sean ;

Blombery, Piers .

BLOOD, 2023, 142

[8] Mature T-cell Lymphomagenesis Induced by Retroviral Insertional Activation of Janus Kinase 1 [J].

Heinrich, Tim ;

Rengstl, Benjamin ;

Muik, Alexander ;

Petkova, Mina ;

Schmid, Frederike ;

Wistinghausen, Robin ;

Warner, Kathrin ;

Crispatzu, Giuliano ;

Hansmann, Martin-Leo ;

Herling, Marco ;

von Laer, Dorothee ;

Newrzela, Sebastian .

MOLECULAR THERAPY, 2013, 21 (06) :1160-1168

[9] Low rate of subsequent malignant neoplasms after CD19 CAR T-cell therapy [J].

Hsieh, Emily M. ;

Myers, Regina M. ;

Yates, Bonnie ;

Annesley, Colleen ;

John, Samuel ;

Taraseviciute, Agne ;

Steinberg, Seth M. ;

Sheppard, Jennifer ;

Chung, Perry ;

Chen, Lee ;

Lee, Daniel W. ;

DiNofia, Amanda ;

Grupp, Stephan A. ;

Verneris, Michael R. ;

Laetsch, Theodore W. ;

Bhojwani, Deepa ;

Brown, Patrick A. ;

Pulsipher, Michael A. ;

Rheingold, Susan R. ;

Gardner, Rebecca A. ;

Gore, Lia ;

Shah, Nirali N. ;

Lamble, Adam J. .

BLOOD ADVANCES, 2022, 6 (17) :5222-5226

[10] Preinfusion factors impacting relapse immunophenotype following CD19 CART cells [J].

Lamble, Adam J. ;

Myers, Regina M. ;

Taraseviciute, Agne ;

John, Samuel ;

Yates, Bonnie ;

Steinberg, Seth M. ;

Sheppard, Jennifer ;

Kovach, Alexandra E. ;

Wood, Brent ;

Borowitz, Michael J. ;

Stetler-Stevenson, Maryalice ;

Yuan, Constance M. ;

Pillai, Vinodh ;

Foley, Toni ;